Kyverna Therapeutics, Inc. — Form D

Kyverna Therapeutics, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-07. The offering totals $152.0M, of which $152.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-11-07
Form: D
Accession: 0001994702-23-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $152.0M
Amount sold: $152.0M
Investors: 24
Date of first sale: 2021-11-09
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-496597

Issuer

Name: Kyverna Therapeutics, Inc.
CIK: 0001994702
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 5980 HORTON STREET, EMERYVILLE, CA, 94608
Phone: 5106268331

Officers, directors & promoters (12)

Name	Role	Location
Ian Clark	Director	SOUTH SAN FRANCISCO, CA
Fred Cohen	Director	AUSTIN, TX
Brian Kotzin	Director	Emeryville, CA
Steve Liapis	Director	Cambridge, MA
Peter Maag	Director	Emeryville, CA
Beth Spiegelman	Director	Emeryville, CA
Dan Spiegelman	Director	Emeryville, CA
Dominic Borie	Executive Officer	Boston, MA
James Chung	Executive Officer	New York City, NY
Ryan Jones	Executive Officer	Bartlesville, OK
Peter Maag	Executive Officer	Emeryville, CA
Karen Walker	Executive Officer	New York, NY

More